Drug conjugate comprising anti-CDH3 (P-cadherin) antibody

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9764041
SERIAL NO

14390734

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

It is an object of the present invention to provide a drug conjugate comprising an anti-CDH3 antibody that efficiently kills cancer cells expressing CDH3. According to the present invention, there is provided an immune complex formed by binding an antibody against CDH3 or a fragment thereof having CDH3 binding ability to a chemotherapeutic agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PERSEUS PROTEOMICS INCTOKYO 153-0041

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ishii, Keisuke Tokyo, JP 35 273
Kayukawa, Yoko Tokyo, JP 6 20
Kouda, Katsushi Tokyo, JP 9 38
Matsuura, Tadashi Tokyo, JP 15 111
Mitomo, Katsuyuki Tokyo, JP 15 60
Nomura, Fumiko Tokyo, JP 10 32

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00